CHE
Chemed Corporation
NYSE · USHealthcareMedical - Care Facilities
$513.68+0.72%
Price as of Jul 20, 2026
CHE financials
Chemed Corporation financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.5B | $2.4B | $2.3B | $2.1B |
| Cost of revenue | $1.8B | $1.6B | $1.5B | $1.4B |
| Gross profit | $758.3M | $854.3M | $798.8M | $765.1M |
| Operating expenses | $417.2M | $487.9M | $458.2M | $421.6M |
| Operating income | $338.2M | $366.5M | $340.6M | $343.5M |
| Net income | $265.2M | $302.0M | $272.5M | $249.6M |
| EBITDA | $422.4M | $464.3M | $414.3M | $393.4M |
| Basic EPS | $18.42 | $20.10 | $18.11 | $16.72 |
| Diluted EPS | $18.42 | $19.89 | $17.93 | $16.53 |
| Balance sheet | ||||
| Cash & equivalents | $74.5M | $178.3M | $264.0M | $74.1M |
| Total assets | $1.6B | $1.7B | $1.7B | $1.4B |
| Total liabilities | $660.6M | $549.6M | $560.2M | $643.3M |
| Stockholders’ equity | $979.4M | $1.1B | $1.1B | $798.7M |
| Total debt | $154.8M | $140.8M | $155.1M | $247.0M |
| Net debt | $80.2M | -$37.5M | -$108.8M | $172.9M |
| Cash flow | ||||
| Operating cash flow | $388.3M | $417.5M | $330.3M | $309.9M |
| Capital expenditure | -$62.8M | -$49.5M | -$56.9M | -$57.3M |
| Free cash flow | $325.5M | $368.0M | $273.4M | $252.6M |
| Dividends paid | -$31.7M | -$27.1M | -$23.5M | -$22.0M |
| Share repurchases | -$431.5M | -$361.4M | -$67.7M | -$114.5M |